is glp 1 insulin What GLP-1 & Does it Affect Weight & Cognition? GLP-1 receptor agonists review and

Description

Urva S, Coskun T, Loghin C, Cui X, Beebe E, O'Farrell L, et al

In general, the use of GLP-1RAs was linked to tolerable rates of adverse events with favorable safety profiles [71, 72]

doi: 10.1016/s0140-6736(65)90761-0

Neuropharmacology (2018) 136(Pt B):2519

The time interval from surgery to the initiation of GLP-1RAs treatment ranged from 1.5 to 86.7 months, with treatment durations between 4 and 12 months

Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-4